Sphera Funds Management’s GSK GSK Stock Holding History

Sphera Funds Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.73M	Hold	122,000	–	–	1.07%	33
2025 Q4	$5.98M	Hold	122,000	–	–	1.16%	33
2025 Q3	$5.27M	Hold	122,000	–	–	1.11%	29
2025 Q2	$4.68M	Sell	122,000 -8,000	-6%	-$306K	1.1%	30
2025 Q1	$5.04M	Hold	130,000	–	–	1.16%	27
2024 Q4	$4.4M	Buy	130,000 +30,000	+30%	+$1.08M	0.79%	46
2024 Q3	$4.09M	Hold	100,000	–	–	0.65%	49
2024 Q2	$3.85M	Hold	100,000	–	–	0.53%	60
2024 Q1	$4.29M	Hold	100,000	–	–	0.6%	53
2023 Q4	$3.71M	Hold	100,000	–	–	0.6%	61
2023 Q3	$3.63M	Hold	100,000	–	–	0.66%	52
2023 Q2	$3.56M	Buy	+100,000	New	+$3.59M	0.56%	61
2019 Q3	–	Sell	-400,000	Closed	-$20M	–	87
2019 Q2	$20M	Buy	400,000 +56,000	+16%	+$2.81M	2.74%	10
2019 Q1	$18M	Buy	344,000 +96,000	+39%	+$4.8M	1.64%	13
2018 Q4	$11.8M	Sell	248,000 -444,000	-64%	-$21.9M	1.34%	20
2018 Q3	$34.7M	Buy	692,000 +80,000	+13%	+$4.06M	3.99%	5
2018 Q2	$30.8M	Buy	612,000 +212,000	+53%	+$10.7M	4.25%	4
2018 Q1	$19.5M	Buy	400,000 +40,000	+11%	+$1.86M	2.97%	8
2017 Q4	$16M	Hold	360,000	–	–	1.87%	8
2017 Q3	$18.3M	Hold	360,000	–	–	2.61%	6
2017 Q2	$19.4M	Buy	+360,000	New	+$19.2M	3.3%	5
2016 Q3	–	Sell	-318,630	Closed	-$6.39M	–	115
2016 Q2	$6.39M	Buy	+318,630	New	+$16.8M	1.66%	12
2015 Q1	–	Sell	-78,560	Closed	-$4.2M	–	155
2014 Q4	$4.2M	Buy	78,560 +880	+1%	+$49.2K	0.72%	41
2014 Q3	$4.46M	Sell	77,680 -162,320	-68%	-$9.95M	0.55%	46
2014 Q2	$16M	Sell	240,000 -280,000	-54%	-$19M	3.95%	6
2014 Q1	$34.7M	Buy	520,000 +80,000	+18%	+$5.41M	7.93%	2
2013 Q4	$29.4M	Buy	+440,000	New	+$28.5M	8.18%	2

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Sphera Funds Management's GSK Position: Q1 2026 in Review

Sphera Funds Management held its GSK (GSK) position steady in Q1 2026 at 122,000 shares worth $6.73M. The position accounts for 1.07% of the portfolio, ranked #33.

Sphera Funds Management first reported a position in GSK in Q4 2013 and has held it in 27 quarters since. The position peaked at $34.7M in Q3 2018. 1,033 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Sphera Funds Management held 122,000 shares of GSK worth $6.73M as of Q1 2026.
Sphera Funds Management left its GSK share count unchanged in Q1 2026.
GSK made up 1.07% of Sphera Funds Management's portfolio in Q1 2026, its #33 holding.
Sphera Funds Management first reported a position in GSK in Q4 2013 and has held it in 27 quarters since.
Sphera Funds Management's GSK position peaked at $34.7M in Q3 2018.
1,033 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Sphera Funds Management's 13F filing for Q1 2026, filed 15 May 2026.